Cardiopoietic cells, produced through cardiogenic conditioning of patients' mesenchymal stem cells, have shown preliminary efficacy. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial aimed to validate cardiopoiesis-based biotherapy in a larger heart failure cohort.

Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

RIBICHINI, Flavio Luciano;KRAMPERA, Mauro;
2016-01-01

Abstract

Cardiopoietic cells, produced through cardiogenic conditioning of patients' mesenchymal stem cells, have shown preliminary efficacy. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial aimed to validate cardiopoiesis-based biotherapy in a larger heart failure cohort.
Cardiopoiesis; Cardiovascular disease; Disease severity; Marker; Precision medicine; Regenerative medicine; Stem cell; Target population
File in questo prodotto:
File Dimensione Formato  
CHART-1.pdf

accesso aperto

Tipologia: Documento in Pre-print
Licenza: Accesso ristretto
Dimensione 681.51 kB
Formato Adobe PDF
681.51 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/957742
Citazioni
  • ???jsp.display-item.citation.pmc??? 73
  • Scopus 138
  • ???jsp.display-item.citation.isi??? 126
social impact